Fang Mei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fang Mei has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Xiaodong Cheng
Department of Integrative Biology & Pharmacology, Texas Therapeutics Institute, University of Texas Health Science Center at Houston, Houston, TX 7000, USA
5 shared publications - Hua Liu
Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch, Galveston, Texas, United States
3 shared publications - Wenbo Zhang
Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch, Galveston, Texas, United States
3 shared publications - Wenli Yang
Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, Texas, USA; The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, The University of Texas Health Science Center, Houston, Texas, USA
3 shared publications Wei Lin
The University of Texas Health Science Center, United States
2 shared publications- Dan Li
Department of Chemical Engineering The University of Melbourne Parkville VIC 3082 Australia
1 shared publication
Latest Publications
- 26 June 2025
- Published by Elsevier in Pharmacological Reviews
- Vol. 77 (5) , 100078
Role of exchange proteins directly activated by cAMP signaling in vascular remodeling
- 26 June 2025
- Published by Elsevier in Pharmacological Reviews
- Vol. 77 (5) , 100078
Role of exchange proteins directly activated by cAMP signaling in vascular remodeling
- 5 April 2024
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 43 (8) , 1389-1399
Role of Ultrasound and Ultrasound‐Based Prediction Model in Differentiating Follicular Thyroid Carcinoma From Follicular Thyroid Adenoma
Objectives: This study aims to identify distinct ultrasound (US) characteristics for distinguishing follicular thyroid carcinoma (FTC) from follicular thyroid adenoma (FTA), and construct a user‐friendly preoperative risk stratification model for thyroid follicular neoplasms.Methods: In this retrospective study, patients diagnosed with pathologically confirmed FTA or FTC and undergoing US examinations between July 2017 and June 2021 were designated as the training cohort, and those from July 2021 to June 2023 were enrolled as the external validation set. We systematically assessed and compared the sonographic and clinical characteristics of FTC and FTA. Univariable and multivariable logistic regression analyses were used to assess the association of US features with FTC in the training set. A prediction nomogram model, incorporating US features independently associated with FTC, was developed and validated externally to assess its performance.Results: A total of 645 patients (FTA/FTC = 530/115) were included in the training set, while 197 patients (FTA/FTC = 165/32) constituted the validation set. In the training set, solid composition, hypo‐echogenicity, irregular margin, calcification, protrusion sign, trabecular formation, absent or thick halo, and mainly central hypervascularity were identified as independent factors associated with FTC. The prediction nomogram model constructed using these variables showed good performance in differentiating FTC from FTA with an area under the curve of 0.948 in the training set and 0.915 in the validation set.Conclusions: The preoperative nomogram model constructed based on US features serves as an effective tool for the risk stratification of thyroid follicular neoplasms.
- 5 April 2024
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 43 (8) , 1389-1399
Role of Ultrasound and Ultrasound‐Based Prediction Model in Differentiating Follicular Thyroid Carcinoma From Follicular Thyroid Adenoma
Objectives: This study aims to identify distinct ultrasound (US) characteristics for distinguishing follicular thyroid carcinoma (FTC) from follicular thyroid adenoma (FTA), and construct a user‐friendly preoperative risk stratification model for thyroid follicular neoplasms.Methods: In this retrospective study, patients diagnosed with pathologically confirmed FTA or FTC and undergoing US examinations between July 2017 and June 2021 were designated as the training cohort, and those from July 2021 to June 2023 were enrolled as the external validation set. We systematically assessed and compared the sonographic and clinical characteristics of FTC and FTA. Univariable and multivariable logistic regression analyses were used to assess the association of US features with FTC in the training set. A prediction nomogram model, incorporating US features independently associated with FTC, was developed and validated externally to assess its performance.Results: A total of 645 patients (FTA/FTC = 530/115) were included in the training set, while 197 patients (FTA/FTC = 165/32) constituted the validation set. In the training set, solid composition, hypo‐echogenicity, irregular margin, calcification, protrusion sign, trabecular formation, absent or thick halo, and mainly central hypervascularity were identified as independent factors associated with FTC. The prediction nomogram model constructed using these variables showed good performance in differentiating FTC from FTA with an area under the curve of 0.948 in the training set and 0.915 in the validation set.Conclusions: The preoperative nomogram model constructed based on US features serves as an effective tool for the risk stratification of thyroid follicular neoplasms.
- Open Access
- 3 May 2023
- Published by Elsevier in Pharmacological Reviews
- Vol. 75 (5) , 979-1006
Paradoxes of Cellular SUMOylation Regulation: A Role of Biomolecular Condensates?
Protein SUMOylation is a major post-translational modification important for maintaining cellular homeostasis. SUMOylation has long been associated with stress responses as a diverse array of cellular stress signals are known to trigger rapid alternations in global protein SUMOylation. In addition, while there are large families of ubiquitination enzymes, all SUMOs are conjugated by a set of enzymatic machinery comprising one heterodimeric SUMO-activating enzyme, a single SUMO-conjugating enzyme, and a small number of SUMO protein ligases and SUMO-specific proteases. How a few SUMOylation enzymes specifically modify thousands of functional targets in response to diverse cellular stresses remains an enigma. Here, we review recent progress toward understanding the mechanisms of SUMO regulation, particularly, the potential roles of liquid-liquid phase separation/biomolecular condensates in the regulation of cellular SUMOylation during cellular stresses. In addition, we discuss the role of protein SUMOylation in pathogenesis and the development of novel therapeutics targeting SUMOylation. Significance Statement Protein SUMOylation is one of the most prevalent post-translational modifications and plays an important role in maintaining cellular homeostasis in response to stresses. Protein SUMOylation has been implicated in human pathogenesis such as cancer, cardiovascular diseases, neurodegeneration, and infection. After more than a quarter century of extensive research, intriguing enigmas remain regarding the mechanism of cellular SUMOylation regulation and the therapeutic potential of targeting SUMOylation.
- 3 May 2023
- Published by Elsevier in Pharmacological Reviews
- Vol. 75 (5) , 979-1006
Open AccessParadoxes of Cellular SUMOylation Regulation: A Role of Biomolecular Condensates?
Protein SUMOylation is a major post-translational modification important for maintaining cellular homeostasis. SUMOylation has long been associated with stress responses as a diverse array of cellular stress signals are known to trigger rapid alternations in global protein SUMOylation. In addition, while there are large families of ubiquitination enzymes, all SUMOs are conjugated by a set of enzymatic machinery comprising one heterodimeric SUMO-activating enzyme, a single SUMO-conjugating enzyme, and a small number of SUMO protein ligases and SUMO-specific proteases. How a few SUMOylation enzymes specifically modify thousands of functional targets in response to diverse cellular stresses remains an enigma. Here, we review recent progress toward understanding the mechanisms of SUMO regulation, particularly, the potential roles of liquid-liquid phase separation/biomolecular condensates in the regulation of cellular SUMOylation during cellular stresses. In addition, we discuss the role of protein SUMOylation in pathogenesis and the development of novel therapeutics targeting SUMOylation. Significance Statement Protein SUMOylation is one of the most prevalent post-translational modifications and plays an important role in maintaining cellular homeostasis in response to stresses. Protein SUMOylation has been implicated in human pathogenesis such as cancer, cardiovascular diseases, neurodegeneration, and infection. After more than a quarter century of extensive research, intriguing enigmas remain regarding the mechanism of cellular SUMOylation regulation and the therapeutic potential of targeting SUMOylation.
- Open Access
- 22 April 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (16) , eabm2960
Epac1 activation by cAMP regulates cellular SUMOylation and promotes the formation of biomolecular condensates
Protein SUMOylation plays an essential role in maintaining cellular homeostasis when cells are under stress. However, precisely how SUMOylation is regulated, and a molecular mechanism linking cellular stress to SUMOylation, remains elusive. Here, we report that cAMP, a major stress-response second messenger, acts through Epac1 as a regulator of cellular SUMOylation. The Epac1-associated proteome is highly enriched with components of the SUMOylation pathway. Activation of Epac1 by intracellular cAMP triggers phase separation and the formation of nuclear condensates containing Epac1 and general components of the SUMOylation machinery to promote cellular SUMOylation. Furthermore, genetic knockout of Epac1 obliterates oxidized low-density lipoprotein–induced cellular SUMOylation in macrophages, leading to suppression of foam cell formation. These results provide a direct nexus connecting two major cellular stress responses to define a molecular mechanism in which cAMP regulates the dynamics of cellular condensates to modulate protein SUMOylation.
- 22 April 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (16) , eabm2960
Open AccessEpac1 activation by cAMP regulates cellular SUMOylation and promotes the formation of biomolecular condensates
Protein SUMOylation plays an essential role in maintaining cellular homeostasis when cells are under stress. However, precisely how SUMOylation is regulated, and a molecular mechanism linking cellular stress to SUMOylation, remains elusive. Here, we report that cAMP, a major stress-response second messenger, acts through Epac1 as a regulator of cellular SUMOylation. The Epac1-associated proteome is highly enriched with components of the SUMOylation pathway. Activation of Epac1 by intracellular cAMP triggers phase separation and the formation of nuclear condensates containing Epac1 and general components of the SUMOylation machinery to promote cellular SUMOylation. Furthermore, genetic knockout of Epac1 obliterates oxidized low-density lipoprotein–induced cellular SUMOylation in macrophages, leading to suppression of foam cell formation. These results provide a direct nexus connecting two major cellular stress responses to define a molecular mechanism in which cAMP regulates the dynamics of cellular condensates to modulate protein SUMOylation.
- Open Access
- 9 January 2020
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 217 (4)
Neuronal Epac1 mediates retinal neurodegeneration in mouse models of ocular hypertension
Progressive loss of retinal ganglion cells (RGCs) leads to irreversible visual deficits in glaucoma. Here, we found that the level of cyclic AMP and the activity and expression of its mediator Epac1 were increased in retinas of two mouse models of ocular hypertension. Genetic depletion of Epac1 significantly attenuated ocular hypertension–induced detrimental effects in the retina, including vascular inflammation, neuronal apoptosis and necroptosis, thinning of ganglion cell complex layer, RGC loss, and retinal neuronal dysfunction. With bone marrow transplantation and various Epac1 conditional knockout mice, we further demonstrated that Epac1 in retinal neuronal cells (especially RGCs) was responsible for their death. Consistently, pharmacologic inhibition of Epac activity prevented RGC loss. Moreover, in vitro study on primary RGCs showed that Epac1 activation was sufficient to induce RGC death, which was mechanistically mediated by CaMKII activation. Taken together, these findings indicate that neuronal Epac1 plays a critical role in retinal neurodegeneration and suggest that Epac1 could be considered a target for neuroprotection in glaucoma.
- 9 January 2020
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 217 (4)
Open AccessNeuronal Epac1 mediates retinal neurodegeneration in mouse models of ocular hypertension
Progressive loss of retinal ganglion cells (RGCs) leads to irreversible visual deficits in glaucoma. Here, we found that the level of cyclic AMP and the activity and expression of its mediator Epac1 were increased in retinas of two mouse models of ocular hypertension. Genetic depletion of Epac1 significantly attenuated ocular hypertension–induced detrimental effects in the retina, including vascular inflammation, neuronal apoptosis and necroptosis, thinning of ganglion cell complex layer, RGC loss, and retinal neuronal dysfunction. With bone marrow transplantation and various Epac1 conditional knockout mice, we further demonstrated that Epac1 in retinal neuronal cells (especially RGCs) was responsible for their death. Consistently, pharmacologic inhibition of Epac activity prevented RGC loss. Moreover, in vitro study on primary RGCs showed that Epac1 activation was sufficient to induce RGC death, which was mechanistically mediated by CaMKII activation. Taken together, these findings indicate that neuronal Epac1 plays a critical role in retinal neurodegeneration and suggest that Epac1 could be considered a target for neuroprotection in glaucoma.
- Open Access
- 3 January 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (1) , eaay3566
Epac1 inhibition ameliorates pathological angiogenesis through coordinated activation of Notch and suppression of VEGF signaling
Epac1 promotes pathological blood vessel formation and is a therapeutic target for vasoproliferative diseases.
- 3 January 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (1) , eaay3566
Open AccessEpac1 inhibition ameliorates pathological angiogenesis through coordinated activation of Notch and suppression of VEGF signaling
Epac1 promotes pathological blood vessel formation and is a therapeutic target for vasoproliferative diseases.
- 1 February 2007
- Published by Trans Tech Publications, Ltd. in Key Engineering Materials
- Vol. 330-332, 377-380
Electrospun Poly(L-lacticacid)/Nano-Hydroxyapatite Hybrid Nanofibers and Their Potential in Dental Tissue Engineering
Efficacy of poly(L-lactic acid) (PLLA)/nano-hydroxyapatite(HA) hybrid nanofibrous scaffolds for dental tissue engineering is described and their performance on normal cells with MG-63 is compared as well in this study. Perfectly PLLA/HA fibrous scaffolds were fabricated by an electrospinning process under optimal condition. Cell culcure and adenovirus encoding green fluorenscent protein technique were used to study the morphology of cells grown on the scaffolds. The results show that the growth of DPSCs and PCs is well observed attached to the PLLA/HA fibers, as well as MG-63, which indicate that the nanofibrous PLLA/HA scaffold could be used as a potential cell carrier in dental tissue engineering.
- 1 February 2007
- Published by Trans Tech Publications, Ltd. in Key Engineering Materials
- Vol. 330-332, 377-380
Electrospun Poly(L-lacticacid)/Nano-Hydroxyapatite Hybrid Nanofibers and Their Potential in Dental Tissue Engineering
Efficacy of poly(L-lactic acid) (PLLA)/nano-hydroxyapatite(HA) hybrid nanofibrous scaffolds for dental tissue engineering is described and their performance on normal cells with MG-63 is compared as well in this study. Perfectly PLLA/HA fibrous scaffolds were fabricated by an electrospinning process under optimal condition. Cell culcure and adenovirus encoding green fluorenscent protein technique were used to study the morphology of cells grown on the scaffolds. The results show that the growth of DPSCs and PCs is well observed attached to the PLLA/HA fibers, as well as MG-63, which indicate that the nanofibrous PLLA/HA scaffold could be used as a potential cell carrier in dental tissue engineering.